Control Bionics offers a suite of speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice.
We’re pleased to welcome Stephen Rix as Chairman of Control Bionics (ASX: $CBL). A long-standing shareholder since 2016, Stephen brings 20+ years of governance and tech leadership as we scale our #neurotech globally. #ASX#CBL#MedTech
A record year and we’re just getting started!
✅ Revenue up 15% YoY
✅ HCPCS driving US growth
✅ NeuroNode® Only scaling globally
✅ NeuroStrip® strong trial results
✅ NeuroBounce® now in AU
📄 Q4 Update: https://t.co/ZEvWwEVKGd
#ASX $CBL #ControlBionics#Medtech#Neurotech
CEO Jeremy Steele on AusbizTV breaks down how $CBL is on track for record FY25 revenue — and what’s powering the momentum.
🧠 Sports & rehab market traction
📈 NeuroStrip® commercialisation
🔓 FY26 catalysts
🎥 Watch: https://t.co/nz0kFaXAkw
#ASX#MedTech#NeuroTech#EMG
Control Bionics (#ASX: $CBL) CEO Jeremy Steele live on @ausbiztv today! We're on track for record FY25 revenue, backed by strong U.S. growth and traction in sports performance, #rehab & assistive tech.
🔗 Watch live: https://t.co/mnhmUejP6W @ 3:10pm AEDT
#Neurotech#sportstech
📈 $CBL trading update: FY25 shaping up as a record revenue year. Core business accelerating + NeuroStrip® scaling into new markets. Read more: https://t.co/YwZhzSiTb0
#ASX#CBL#EMG#MedTech#RehabTech#SportsPerformance
Thanks to @StockheadAU for this article on the Big Freeze shining a spotlight on #MND. At Control Bionics, we’re helping people living with MND/ALS regain communication and control through our NeuroNode® technology. #ASX#Medtech $CBL #AssistiveTech#NeuroNode
📢 Control Bionics at #ImpactInvestingSummit
Our CEO Jeremy Steele spoke on the panel "Scaling Solutions Helping Young Australians with Disabilities", sharing how #tech#innovation is improving access to assistive communication, mobility & rehab.
#AssistiveTechnology#NeuroTech
📢 Control Bionics at #ATIA2025! Industry leaders embraced our new HCPCS code approval, expanding access to #NeuroNode®. This milestone opens new distribution opportunities, advancing #Accessibility with innovative #AssistiveTechnology.
Thanks to @StockheadAU TV for this superb roundup of our key 2024 achievements and what we're aiming for in 2025! ASX: $CBL on #Vimeo https://t.co/SLp7woh9Jb
Big milestone for Control Bionics (#ASX: $CBL): First commercial agreements for NeuroStrip® technology in US sports & Japanese #rehabilitation , driving SaaS revenue, hardware sales, & global growth.
#NeuroStrip#ControlBionics#SportsPerformance Read: https://t.co/owPvBkSt17
Thanks to @australian for featuring Control Bionics (ASX:CBL) and highlighting:
✅ U.S. expansion with NeuroNode & Medicare reimbursement secured
✅ New product launch: NeuroStrip
✅ Strategic shift to wholesale distribution
Read: https://t.co/Xtan1Ajlxy
#AssistiveTech